Introduction/Overview
Epigallocatechin (EGC), as one of the most abundant catechins in tea, is the core active ingredient of green tea polyphenols. Its chemical name is (-) - epigallocatechin gallate, CAS number 970-74-1, and it is a flavan-3,3 ', 4', 5,5 ', 7-hexanol with a (2R, 3R) - configuration. For a long time, the health benefits of green tea, such as antioxidant, anti-inflammatory, anti-tumor, and cardiovascular protection effects, have been widely attributed to its rich catechin compounds, among which EGC plays an indispensable role. With the rapid development of modern pharmacology and molecular biology techniques, the biological effects of EGC have evolved from describing macroscopic physiological phenomena to analyzing microscopic molecular mechanisms. Especially its core role in regulating oxidative stress response makes it a potential natural candidate drug for combating various chronic diseases such as neurodegenerative diseases, metabolic syndrome, cancer, etc. This article aims to systematically review the chemical properties, plant sources, pharmacological activities, molecular mechanisms of action, pharmacological evaluation, and clinical application prospects of EGC, in order to provide comprehensive scientific references for the in-depth research and development of this natural product.
Chemical structure and physicochemical properties
Epigallocatechin gallate belongs to the class of catechins, which are flavan-3-ol compounds. Its molecular formula is C15H14O7 and its molecular weight is 306.27 g/mol. Its core structure is a benzodihydropyran (yellow alkane) skeleton, which is in the cis configuration ("epigenetic" configuration) at the C2 and C3 positions, and both are in the R configuration. Compared with other catechins (such as epicatechin EC), EGC has three consecutive phenolic hydroxyl groups (3 ', 4', 5 'positions) on its B ring, which is the chemical basis for its strong antioxidant activity. The 5,7 positions on the A ring are also substituted with dihydroxy groups, while the 3 positions on the C ring are hydroxyl groups.
From the analysis of physical and chemical properties, EGC molecules contain six phenolic hydroxyl groups, making them highly polar and hydrophilic. The calculated topological polar surface area (TPSA) is as high as 130.61 Å ², and the theoretical lipid water partition coefficient (LogP) is about 0.82, indicating good solubility in the aqueous phase (about 0.84 mg/mL) and belonging to hydrophilic molecules. This property determines its distribution characteristics within the organism, for example, its ability to cross the blood-brain barrier is predicted to be low, which to some extent limits its direct effect on central nervous system diseases, but also suggests the importance of its peripheral effects. In addition, the multiple phenolic hydroxyl groups in EGC make it unstable in alkaline or oxidative environments, making it prone to isomerization or oxidative polymerization, which poses challenges to its extraction, preservation, and in vivo bioavailability. The preliminary screening of in vitro genetic toxicity (Ames test) showed a negative result (0.6), indicating a low risk of genetic toxicity and no significant inhibitory effect on hERG potassium channels, suggesting a low potential risk of cardiac toxicity and providing preliminary evidence for its safety evaluation.
Plant sources and extraction methods
EGC mainly exists in the leaves of Camellia sinensis, a plant in the Theaceae family. It is one of the most abundant catechins in unfermented or lightly fermented teas such as green tea, white tea, and oolong tea. Its content is significantly affected by tea tree variety, growth environment, picking season, and processing technology. Generally speaking, the content in tender leaves is higher than that in old leaves, and spring tea is higher than summer and autumn tea. In addition to tea, trace amounts are also present in some fruits (such as cranberries, blackberries) and nuts, but tea is its most economical and primary source.
The extraction of EGC from tea usually follows the general extraction process of plant polyphenols. The solvent extraction method is the most commonly used method, in which water, ethanol, methanol, and their mixed solutions in different proportions are the main solvents. In order to improve extraction efficiency and selectivity, modern extraction techniques have been widely applied:
1. Microwave assisted extraction Using microwave energy to quickly heat plant cells, destroy cell walls, and accelerate the dissolution of active ingredients such as EGC has the advantages of short time, high efficiency, and low solvent dosage.
2. Ultrasound assisted extraction The cavitation effect, mechanical vibration, and thermal effect generated by ultrasound can promote solvent penetration and component diffusion, which can also significantly improve the extraction rate.
3. Supercritical fluid extraction Usually, carbon dioxide is used as the extractant and operated under conditions close to room temperature, which can effectively avoid the oxidation and degradation of thermosensitive components such as EGC, and obtain high-purity products, but the equipment cost is relatively high.
The crude extract contains various components such as EGC, epigallocatechin gallate (EGCG), caffeine, amino acids, etc., which need further separation and purification. Column chromatography techniques are often used, such as macroporous adsorption resin chromatography, dextran gel chromatography and high-performance liquid preparation chromatography. Among them, semi preparative or preparative high-performance liquid chromatography is the most effective means to obtain high-purity EGC monomers, which can achieve high-purity preparation from milligrams to grams, meeting the needs of pharmacological research.
Pharmacological activity research
A large number of in vitro and in vivo studies have shown that EGC has a wide range of pharmacological activities, with its core centered around antioxidant activity and extending to multiple fields such as anti-inflammatory, anti-tumor, neuroprotection, cardiovascular protection, and metabolic regulation.
-
antioxidant activity EGC is a potent natural antioxidant. The triphenylphenol structure on its B ring enables it to efficiently provide hydrogen atoms or electrons, directly scavenging reactive oxygen/nitrogen species such as superoxide anions, hydroxyl radicals, and peroxynitrite. In addition, it can chelate transition metal ions (such as Fe ² ⁺, Cu ² ⁺) to prevent their participation in the Fenton reaction and the generation of hydroxyl radicals. Cell and animal experiments have confirmed that EGC pretreatment can significantly alleviate oxidative damage induced by exogenous stimuli such as hydrogen peroxide, paraquat, and radiation, and protect DNA, proteins, and lipids from oxidative damage.
-
anti-inflammatory effect Chronic inflammation is closely related to oxidative stress. EGC can inhibit the production of various inflammatory mediators. Research has shown that EGC can downregulate the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in macrophages stimulated by lipopolysaccharides and reduce the production of nitric oxide and prostaglandin E2. At the same time, it can also inhibit the secretion of key pro-inflammatory cytokines such as tumor necrosis factor - α (TNF - α), interleukin-1 β (IL-1 β), and IL-6. Its anti-inflammatory mechanism is closely related to its antioxidant and regulation of inflammatory signaling pathways.
-
Antitumor potential EGC can inhibit the growth and induce apoptosis of many tumor cell lines (such as breast cancer, prostate cancer, lung cancer, colon cancer). The mechanism involves inducing cell cycle arrest (often in the G1 phase), activating the caspase cascade, regulating the Bcl-2/Bax protein ratio, and inhibiting the activation of nuclear factor kappa B (NF - κ B). It is worth noting that EGC has relatively low toxicity to normal cells and exhibits a certain degree of selectivity.
-
Neuroprotective effect EGC has shown protective effects in models of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. It can reduce beta amyloid induced neuronal toxicity, inhibit abnormal aggregation of alpha synuclein, and protect dopaminergic neurons. Although its blood-brain barrier permeability is limited, it is still considered a potential neuroprotective agent through indirect pathways such as reducing peripheral inflammation, regulating gut microbiota, and the potential role of its metabolites.
-
Cardiovascular and Metabolic Protection EGC can help to improve the function of vascular endothelium, inhibit the oxidation of low-density lipoprotein, and prevent platelet aggregation, thus playing an anti atherosclerotic role. In metabolism, studies have shown that EGC can improve insulin sensitivity, inhibit adipocyte differentiation, promote fatty acid oxidation, and has a potential improvement effect on obesity and type 2 diabetes.
Mechanism of action and molecular targets
The pharmacological effects of EGC are not achieved through a single target, but through the synergistic action of multiple targets and pathways. Among them, combating oxidative damage is its most core biological effect, involving a series of key molecular targets and signaling pathways.
Core mechanism: Activation of Nrf2/ARE antioxidant defense pathway
The key molecular mechanism of EGC's antioxidant effect is the activation of the nuclear factor E2 related factor 2 (Nrf2, encoded by the NFE2L2 gene) signaling pathway. In the resting state, Nrf2 binds to its inhibitory protein Keap1 in the cytoplasm and is degraded by ubiquitination. After EGC enters the cell, its phenolic hydroxyl group can covalently modify specific cysteine residues in Keap1 protein, or change the conformation of Keap1 by generating slight redox perturbations, thereby dissociating Nrf2. The free Nrf2 translocates to the nucleus, forms a heterodimer with Maf protein, and binds to the antioxidant response element (ARE), initiating gene transcription of a series of downstream phase II detoxifying enzymes and antioxidant proteins.
Key downstream target genes include：
* SOD1 (Superoxide Dismutase 1) and SOD2 (Superoxide Dismutase 2)Catalyzing the conversion of superoxide anions into hydrogen peroxide in both cytoplasm and mitochondria is the first line of defense against oxidation.
* CAT (catalase)Mainly located in peroxisomes, it catalyzes the decomposition of hydrogen peroxide into water and oxygen.
* GPX1 (Glutathione Peroxidase 1)Using reduced glutathione (GSH) to reduce hydrogen peroxide and organic hydroperoxides into harmless alcohols and water.
* HMOX1 (Heme Oxygenase 1)Degradation of hemoglobin produces biliverdin (a strong antioxidant), carbon monoxide, and iron ions, which have strong anti-inflammatory and antioxidant stress resistance abilities.
By systematically enhancing the cell's own antioxidant defense system, EGC helps cells maintain redox homeostasis, which is considered the fundamental basis for its anti-inflammatory, anti apoptotic, anti-aging, and other benefits. In addition, EGC can directly or indirectly regulate other signaling pathways, such as inhibiting NF - κ B activation (anti-inflammatory), activating AMPK (regulating energy metabolism), inhibiting PI3K/Akt/mTOR (anti proliferative), etc. These pathways interact extensively with the Nrf2 pathway, forming a complex and precise pharmacological network of EGC.
Evaluation of drug properties and pharmacokinetics
Although EGC exhibits excellent biological activity in vitro, its main challenges in drug development lie in poor pharmacokinetic properties and bioavailability.
Absorption, distribution, metabolism, and excretion：
EGC is mainly absorbed in the small intestine after oral administration, but its absorption rate is relatively low (estimated to be<5%). The absorption process involves passive diffusion and possible carrier mediated transport. EGC that enters the bloodstream undergoes rapid and widespread phase II metabolism, mainly through methylation, glucuronidation, and sulfation in the liver and intestines, producing various metabolic products. The prototype drug has a low concentration in plasma and a short half-life (about 1-2 hours). The hydrophilicity of EGC limits its tissue distribution and makes it difficult to penetrate the blood-brain barrier. It is mainly distributed in organs with abundant blood flow, such as the liver and kidneys. Its excretion pathway is mainly through the kidneys and urine, and the excretion rate of metabolites is relatively fast.
Challenges and improvement strategies for drug development：
1. Low bioavailability The reasons include low intestinal absorption rate, strong first pass metabolism, and poor chemical stability (easily oxidized or isomerized in neutral/alkaline intestinal environments).
2. Chemical stability issues EGC is unstable in solution, especially under light, heat, and alkaline conditions.
3. Improvement strategy：
* Structural modification By chemical modifications such as esterification and methylation, its lipid solubility and metabolic stability are improved. For example, preparing its liposomes and prodrugs (such as EGC palmitate).
* delivery system Using nanotechnology, such as liposomes, nanoemulsions, polymer nanoparticles, solid lipid nanoparticles, etc., to encapsulate EGC can effectively protect it from degradation, enhance intestinal absorption, achieve targeted delivery, and prolong its in vivo circulation time.
* combination therapy Combined with substances such as vitamin C and piperine, it can inhibit the metabolism of EGC and improve its bioavailability.
Clinical application prospects and prospects
Based on solid preclinical research evidence, EGC has shown broad application prospects in the prevention and adjuvant treatment of various diseases.
- Disease Prevention and Health Products As a dietary supplement or functional food ingredient, it is used for daily antioxidant, anti-aging, and immune enhancement. This is currently the most direct application form of EGC.
- Chronic inflammatory diseases For conditions such as arthritis and inflammatory bowel disease, the anti-inflammatory and antioxidant properties of EGC may serve as an adjuvant therapy to alleviate tissue damage and symptoms.
- Metabolic diseases EGC has potential value in the prevention and treatment of obesity, type 2 diabetes and nonalcoholic fatty liver by regulating glucose and lipid metabolism and improving insulin resistance.
- Neurodegenerative diseases Although it is difficult to directly enter the brain, EGC has the potential to become a part of disease modifying therapies for Alzheimer's and Parkinson's diseases through nano delivery systems or the development of derivatives that can penetrate the blood-brain barrier.
- Chemotherapy prevention and adjuvant therapy for tumors EGC may be used for tumor chemoprevention in high-risk populations or in combination with conventional radiotherapy and chemotherapy to enhance efficacy and reduce side effects.
Future research should focus on:
* In depth mechanism exploration Using omics techniques (proteomics, metabolomics) and gene editing tools to more accurately depict the functional network of EGC in specific disease models.
* Development of new derivatives and formulations Committed to developing EGC derivatives and advanced delivery systems with higher stability, bioavailability, and targeting.
* High quality clinical research Conduct rigorously designed, large sample, multicenter randomized controlled clinical trials to clarify the effective dosage, long-term safety, and exact efficacy of EGC in different disease populations.
* Multi component collaborative research Study the synergistic effects of EGC with other tea components (such as EGCG, theanine) or drugs, and explore the potential of compound applications.
Conclusion
Epigallocatechin gallate, as a key active ingredient in tea, has a strong antioxidant capacity that mediates a wide range of pharmacological effects such as anti-inflammatory, anti-tumor, neuroprotective, and metabolic regulation by activating core pathways such as Nrf2. Despite facing challenges such as low bioavailability and poor stability during the drug manufacturing process, these bottlenecks are gradually being overcome with the deepening understanding of molecular mechanisms and the innovation of drug delivery technology. From traditional tea drinking culture to modern precision medicine, EGC's research spans thousands of years of wisdom and modern technology. It is not only a classic model for exploring the pharmacological effects of natural products, but also a valuable resource for developing new prevention and treatment strategies. In the future, through interdisciplinary collaboration, epigallocatechin gallate is expected to transform from a well-known dietary ingredient into drugs or health products with clear clinical value, making greater contributions to human health.
